HDAC inhibitors reverse acquired radio resistance of KYSE-150R esophageal carcinoma cells by modulating Bmi-1 expression
- PMID: 24459703
HDAC inhibitors reverse acquired radio resistance of KYSE-150R esophageal carcinoma cells by modulating Bmi-1 expression
Abstract
Tumors treated with fractionated doses of ionizing radiation (IR) often acquire radioresistance. Although histone deacetylase inhibitors (HDIs) have been demonstrated to sensitize intrinsic radioresistant cancer cell lines to IR, little is known on the impact of HDIs on the effects of IR in acquired radioresistant cancer cells. This study evaluates the mechanisms by which HDIs sensitize acquired radioresistant esophageal squamous cell carcinoma cells to IR. The HDIs trichostatin A and sodium butyrate were tested for the irability to sensitize acquired radioresistant KYSE-150R and radiosensitive KYSE-150 parental cells to IR. Although the HDIs induced similar levels of cytotoxicity in the KYSE-150 and the KYSE-150R cells, HDIs increased the: (i) radiosensitivity, (ii) IR-induced ROS generation, and (iii) IR-induced G2/M arrest and apoptosis of KYSE-150R cells compared with those of KYSE-150 cells. These changes were accompanied by increased p21 expression and decreased mitochondrial membrane potential. When combined with IR, HDIs inhibited Bmi-1 expression in KYSE-150R cells and their ability to repair DNA damage. The results demonstrate the potential utility of HDIs in augmenting the efficacy of fractionated radiotherapy.
Similar articles
-
Bmi-1 confers adaptive radioresistance to KYSE-150R esophageal carcinoma cells.Biochem Biophys Res Commun. 2012 Aug 24;425(2):309-14. doi: 10.1016/j.bbrc.2012.07.087. Epub 2012 Jul 25. Biochem Biophys Res Commun. 2012. PMID: 22842564
-
Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab.Radiother Oncol. 2009 Dec;93(3):468-73. doi: 10.1016/j.radonc.2009.08.008. Epub 2009 Sep 8. Radiother Oncol. 2009. PMID: 19744737
-
FH535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line KYSE-150R.J Transl Med. 2015 Mar 31;13:104. doi: 10.1186/s12967-015-0464-6. J Transl Med. 2015. PMID: 25888911 Free PMC article.
-
Mechanism of Action for HDAC Inhibitors-Insights from Omics Approaches.Int J Mol Sci. 2019 Apr 1;20(7):1616. doi: 10.3390/ijms20071616. Int J Mol Sci. 2019. PMID: 30939743 Free PMC article. Review.
-
Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy.Int J Mol Sci. 2022 Sep 26;23(19):11343. doi: 10.3390/ijms231911343. Int J Mol Sci. 2022. PMID: 36232638 Free PMC article. Review.
Cited by
-
Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy.Oncol Rep. 2017 Apr;37(4):2382-2390. doi: 10.3892/or.2017.5478. Epub 2017 Feb 28. Oncol Rep. 2017. PMID: 28260023 Free PMC article.
-
Role of metabolism in cancer cell radioresistance and radiosensitization methods.J Exp Clin Cancer Res. 2018 Apr 23;37(1):87. doi: 10.1186/s13046-018-0758-7. J Exp Clin Cancer Res. 2018. PMID: 29688867 Free PMC article. Review.
-
mRNA and methylation profiling of radioresistant esophageal cancer cells: the involvement of Sall2 in acquired aggressive phenotypes.J Cancer. 2017 Feb 25;8(4):646-656. doi: 10.7150/jca.15652. eCollection 2017. J Cancer. 2017. PMID: 28367244 Free PMC article.
-
NVP-BSK805, an Inhibitor of JAK2 Kinase, Significantly Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma in vitro and in vivo.Drug Des Devel Ther. 2020 Feb 24;14:745-755. doi: 10.2147/DDDT.S203048. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32158193 Free PMC article.
-
Properties and gene expression profiling of acquired radioresistance in mouse breast cancer cells.Ann Transl Med. 2021 Apr;9(8):628. doi: 10.21037/atm-20-4667. Ann Transl Med. 2021. PMID: 33987326 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical